Miguel Maia obtained his MSc in Pharmaceutical Sciences in 2013 at the Faculty of Pharmacy, University of Porto.
He has worked as a Stability and Validation Specialist in the pharmaceutical industry for five years and is currently a PhD student at CIIMAR (Interdisciplinary Centre of Marine and Environmental Research, Porto, Portugal). I
ts research project focuses on the design and synthesis of novel compounds against Alzheimer’s disease.
He joined Baumann group in September 21 in order to apply the flow technology to his own research project.
Tilly joined our group for 8 weeks during the Summer trimester 2021.
She focused her studies on the synthesis of indazole structures in both batch and flow mode.